publicações selecionadas
-
artigo académico
- Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. Molecular Biology Reports. 2020
- Loss of SPINT2 expression frequently occurs in glioma, leading to increased growth and invasion via MMP2. Cellular Oncology. 2020
- Genetic variants of vascular endothelial growth factor predict risk and survival of gliomas. Tumor Biology. 2018
- Effects of the functional HOTAIR rs920778 and rs12826786 genetic variants in glioma susceptibility and patient prognosis. Journal of Neuro-Oncology. 2017
- Impact of TGF-ß1 -509C/T and 869T/C polymorphisms on glioma risk and patient prognosis. Tumor Biology. 2015
- Immunoglobulin genes implicated in glioma risk. Oncoimmunology. 2014
- Impact of EGFR genetic variants on glioma risk and patient outcome. Cancer Epidemiology Biomarkers & Prevention. 2011
- Prognostic value of MGMT promoter methylation in glioblastoma patients treated with temozolomide-based chemoradiation: A Portuguese multicentre study. Oncology Reports. 2010
- TP53 codon 72 polymorphism in susceptibility, overall survival, and adjuvant therapy response of gliomas. Cancer Genetics and Cytogenetics. 2008
-
documento